SALIX PHARMACEUTICALS LTD Accounts Receivable
SALIX PHARMACEUTICALS LTD had Accounts Receivable of $42.52 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2015-03-02
- 2014-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $42.52M.
- 2014-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $507.43M; Accounts Receivable, after Allowance for Credit Loss, Current as first filed $522.63M.
- 2014-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $481.49M.
- 2014-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $437.56M; Accounts Receivable, after Allowance for Credit Loss, Current as first filed $438.55M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2014-12-31 | $42.52M 10-K · filed 2015-03-02 | |
| 2014-09-30 | $507.43M 10-Q/A · filed 2015-03-02 | $522.63M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $481.49M 10-Q/A · filed 2015-03-02 | |
| 2014-03-31 | $437.56M 10-Q/A · filed 2015-03-02 | $438.55M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $133.58M 10-K · filed 2015-03-02 | $147.93M 10-K · filed 2014-02-28 |
| 2013-09-30 | $389.75M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $282.77M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $111.52M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $268.24M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $213.77M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $211.68M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $193.20M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $151.21M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $169.91M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $152.09M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $101.48M 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $140.18M 10-K · filed 2012-02-28 |